Skip to main content
SpringerLink
Log in

Cost-Effectiveness of Catheter Ablation for Atrial Fibrillation

  • Chapter
Atrial Fibrillation

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 1598 Accesses

Abstract

Atrial fibrillation (AF) is the most common supraventricular tachyarrhythmia encountered in clinical practice. The incidence and prevalence of this arrhythmia continue to rise. Strategies for the management of atrial fibrillation include rate or rhythm control. Rhythm control can be attempted pharmacologically, surgically, or more recently by the use of catheter ablation. Catheter ablation of AF is now a widely accepted and practiced treatment modality. The cost-effectiveness of this technique hinges on procedural success rates, complication rates, up-front costs, and the stroke risk in the treatment population. There have been several studies of the cost-effectiveness of catheter ablation of AF compared with pharmacological management. Most of these studies projected a time horizon of at least 5 years before catheter ablation becomes cost-effective. As techniques become more uniform and widespread, the efficacy is likely to increase, with a reduction in complication rate, leading to a reduced time horizon for making this procedure cost-effective. A prospective, randomized, multicenter study is required to definitively establish the cost-effectiveness of this procedure.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. 1. Teng MP, Catherwood E, Melby DP. Cost effectiveness of therapies for atrial fibrillation, a review. Pharmacoeconomics. 2000;18:317–333.

    Article  CAS  PubMed  Google Scholar 

  2. 2. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke. 1991;22:983–988.

    CAS  PubMed  Google Scholar 

  3. 3. Wattigney WA, Mensah GA, Croft JB. Increased atrial fibrillation mortality: United States, 1980–1998. Am J Epidemiol. 2002;155:819–826.

    Article  PubMed  Google Scholar 

  4. 4. Wolf PA, Benjamin EJ, Belanger AJ, Kannel WB, Levy D, D'Agostino RB. Secular trends in the prevalence of atrial fibrillation: The Framingham Study. Am Heart J. 1996;131:790–795.

    Article  CAS  PubMed  Google Scholar 

  5. 5. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347:1825–1833.

    Article  CAS  PubMed  Google Scholar 

  6. 6. Marshall DA, Levy AR, Vidaillet H, Fenwick E, Slee A, Blackhouse G, Greene H L, Wyse GD, Nichol G, O'Brien BJ. Cost-effectiveness of rhythm vs rate control in atrial fibrillation. Ann Intern Med. 2004;141:653–661.

    PubMed  Google Scholar 

  7. 7. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley S D. Relationships between sinus rhythm, treatment, and survival in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study. Circulation. 2004;109:1509–1513.

    Article  PubMed  Google Scholar 

  8. 8. Weerasooriya R, Jais P, Le Heuzey J-Y, Scavee C, Choi K-J, Macle L, Raybaud F, Hocini, Shah D, Lavergne T, Clementy J, Haissaguerre M. Cost analysis of catheter ablation for paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 2003;26(2):292–294.

    Article  PubMed  Google Scholar 

  9. 9. Le Heusey JY, Piot O, Paziaud S. Cost of care in atrial fibrillation [abstract]. Eur Heart J. 2000;21(suppl):473.

    Google Scholar 

  10. 10. Kanj M, Wazni O, Natale A. How to do circular mapping catheter-guided pulmonary vein antrum isolation: the Cleveland Clinic approach. Heart Rhythm. 2006;3:866–869.

    Article  PubMed  Google Scholar 

  11. 11. Khaykin Y, Skanes A, Morillo C A, McCraken A, Humphries K, Kerr CA. Catheter ablation is a cost effective alternative to medical therapy in atrial fibrillation. Heart Rhythm. 2006;3S:7.

    Article  Google Scholar 

  12. 12. Lim TW, Jassal IS, Ross DL, Thomas SP. Medium-term efficacy of segmental ostial pulmonary vein isolation for the treatment of permanent and persistent atrial fibrillation. Pacing Clin Electrophysiol. 2006;29:374–379.

    Article  PubMed  Google Scholar 

  13. 13. Earley MJ, Abrams DJ, Staniforth AD, Sporton SC, Schilling RJ. Catheter ablation of permanent atrial fibrillation: medium term results. Heart. 2006;92:233–238.

    Article  CAS  PubMed  Google Scholar 

  14. 14. Chan PS, Vijan S, Morady F, Oral H. Cost-effectiveness of radiofrequency catheter ablation for atrial fibrillation. J Am Coll Cardiol. 2006;47:2513–2520.

    Article  PubMed  Google Scholar 

  15. 15. Rascati KL. The $64,000 question—what is a quality-adjusted life-year worth? Clin Ther. 2006;28:1042–1043.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Electrophysiology Clinical Fellow, Cardiac Pacing and Electrophysiology, Cleveland Clinic Foundation, Cleveland, OH, USA

    John Meulet (MBBS (Hons) FRACP) & Mohamed Kanj (MD)

  2. Staff Electrophysiologist, Cardiac Pacing and Electrophysiology, Cleveland Clinic Foundation, Cleveland, OH, USA

    David O. Martin

Authors
  1. John Meulet
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohamed Kanj
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David O. Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA

    Andrea Natale MD (Executive Medical Director of the Texas Cardiac Arrhythmia Institute, Consulting Professor) (Executive Medical Director of the Texas Cardiac Arrhythmia Institute, Consulting Professor)

  2. Division of Cardiology, Stanford University, Palo Alto, CA, USA

    Andrea Natale MD (Executive Medical Director of the Texas Cardiac Arrhythmia Institute, Consulting Professor) (Executive Medical Director of the Texas Cardiac Arrhythmia Institute, Consulting Professor)

  3. University of Michigan, Ann Arbor, MI, USA

    José Jalife MD (Professor of Internal Medicine, The Cyrus and Jane Farrehi Professor of Cardiovascular Research, Professor of Molecular and Integrative Physiology) (Professor of Internal Medicine, The Cyrus and Jane Farrehi Professor of Cardiovascular Research, Professor of Molecular and Integrative Physiology)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Meulet, J., Kanj, M., Martin, D.O. (2008). Cost-Effectiveness of Catheter Ablation for Atrial Fibrillation. In: Natale, A., Jalife, J. (eds) Atrial Fibrillation. Contemporary Cardiology. Humana Press. https://doi.org/10.1007/978-1-59745-163-5_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-163-5_3

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-856-0

  • Online ISBN: 978-1-59745-163-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation